Chris Whitty
Chris Whitty is a prominent figure in the field of medicine and public health, currently serving as the Chief Medical Officer for England (CMO) and the UK government's Chief Medical Adviser. Born on 21 April 1966, Whitty has had a distinguished career in medicine and has been instrumental in the UK's response to the COVID-19 pandemic.
Early Life and Education[edit]
Whitty was born in Gloucester, England. He attended Tonbridge School, a prestigious independent school in Kent, before going on to study at Pembroke College, Oxford, where he graduated with a degree in physiology. He later studied medicine at GKT School of Medical Education, King's College London, and graduated in 1991. He also holds an MSc in Public Health from the London School of Hygiene & Tropical Medicine.
Career[edit]
Whitty's career has spanned various roles in both clinical medicine and public health. He worked as a consultant in tropical medicine at the Hospital for Tropical Diseases, London, and was involved in several overseas projects, particularly in Africa, dealing with malaria and HIV/AIDS.
In 2008, he was appointed as the Chief Scientific Adviser for the Department for International Development (DFID), where he advised on medical and scientific matters, particularly in relation to developing countries.
In 2019, Whitty was appointed as the Chief Medical Officer for England and the UK government's Chief Medical Adviser. In this role, he has been a key figure in the UK's response to the COVID-19 pandemic, regularly appearing in government briefings and advising on public health measures.
Personal Life[edit]
Whitty is known for his dedication to his work and his private nature. He is unmarried and has no children.
Recognition[edit]
Whitty's work has been widely recognised. In 2009, he was awarded the Manson Medal, the highest award of the Royal Society of Tropical Medicine and Hygiene. In 2015, he was made a Companion of the Order of the Bath in the Queen's Birthday Honours.
References[edit]
<references />
-
Chris Whitty
-
Chris Whitty
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
